Versant Ventures
Early and late stage life sciences VC firm investing in the US and Europe
About This Fund
Versant Ventures is an early and late-stage venture capital firm that invests in the US and Europe. It makes the investment in life sciences companies operating in sectors such as Biopharma, Medical Devices, Diagnostics, etc. Some of the notable portfolio companies are Jazz Pharmaceuticals, Blue Rock Therapeutics, AcuFocus, CymaBay Therapeutics, etc. The firm manages over $2.3B assets under management.
Investment Focus
What They Look For
Academic founders or experienced biotech teams; US, Canada, Europe (esp. Switzerland); breakthrough therapeutics for serious diseases; sustainable business models with dual liquidity paths
Preparing to pitch Versant Ventures?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →